Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?
Prostate cancer (PC) remains a cause of death worldwide. Here we investigate whether a single microfocus of PC at the biopsy (graded as Gleason 6 or less, ≤5% occupancy) and the PSA
Gespeichert in:
Veröffentlicht in: | Journal of Oncology 2012-01, Vol.2012 (2012), p.486-491-051 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 491-051 |
---|---|
container_issue | 2012 |
container_start_page | 486 |
container_title | Journal of Oncology |
container_volume | 2012 |
creator | Taverna, Gianluigi Benecchi, Luigi Grizzi, Fabio Seveso, Mauro Giusti, Guido Piccinelli, Alessandro Benetti, Alessio Colombo, Piergiuseppe Minuti, Francesco Graziotti, Pierpaolo |
description | Prostate cancer (PC) remains a cause of death worldwide. Here we investigate whether a single microfocus of PC at the biopsy (graded as Gleason 6 or less, ≤5% occupancy) and the PSA |
doi_str_mv | 10.1155/2012/645146 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3403479</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><airiti_id>P20151203007_201212_201702210006_201702210006_486_491_051</airiti_id><sourcerecordid>1034798751</sourcerecordid><originalsourceid>FETCH-LOGICAL-a441t-6cda11f1a7303aff841819b86e49478b215bc6e9ef7358221a012501d201bc8f3</originalsourceid><addsrcrecordid>eNqFks1u1DAUhSMEoqWwYg3yEoHC-CZO4myKplMoSIM64mdtOc71jEvGHuyk1bwLr8Ab8E68Ap6mDO2KhWVb99O51-c4SZ4CfQ1QFJOMQjYpWQGsvJccQsmrlLOC3r91PkgehXBBacloXT5MDrKMM54BP0x-zqQlkpx1KIOzpCTOkzmGQD4a5Z12agjEabLwLvSyRxJxhZ4YS84tkhPjNmFLpG33RPp5g8poo8jU9maJNspdYkd-__oBlNjlZD0nJ0hOURuLLZGB9CskU69W2G83uGs2d1fpJxO-_et6akKcD988Th5o2QV8crMfJV_fvf0ye5_Oz88-zKbzVDIGfVqqVgJokFVOc6k1Z8ChbniJrGYVbzIoGlVijbrKC55lIKOFBYU2WtkorvOj5HjU3QzNGluFtveyExtv1tJvhZNG3K1YsxJLdylyRnNW1VHgxY2Ad98HDL1Ym6Cw66RFNwQB1xivCojoqxGNfofgUe_bABW7gMUuYDEGHOnntyfbs38TjcDLEVgZ28or8x-1ZyOMEUEt9zDjVVXQWF-MdWm86Y24cIO30XixiCoFZDSntLpWjJpxq2g0k8Z_dvfCeFw1CBqf-wdiYs1n</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1034798751</pqid></control><display><type>article</type><title>Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?</title><source>Wiley-Blackwell Open Access Titles</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Taverna, Gianluigi ; Benecchi, Luigi ; Grizzi, Fabio ; Seveso, Mauro ; Giusti, Guido ; Piccinelli, Alessandro ; Benetti, Alessio ; Colombo, Piergiuseppe ; Minuti, Francesco ; Graziotti, Pierpaolo</creator><contributor>Roach, M.</contributor><creatorcontrib>Taverna, Gianluigi ; Benecchi, Luigi ; Grizzi, Fabio ; Seveso, Mauro ; Giusti, Guido ; Piccinelli, Alessandro ; Benetti, Alessio ; Colombo, Piergiuseppe ; Minuti, Francesco ; Graziotti, Pierpaolo ; Roach, M.</creatorcontrib><description>Prostate cancer (PC) remains a cause of death worldwide. Here we investigate whether a single microfocus of PC at the biopsy (graded as Gleason 6 or less, ≤5% occupancy) and the PSA <10 ng/mL can define the archetype of low-risk prostate disease. 4500 consecutive patients were enrolled. Among them, 134 patients with a single micro-focus of PC were followed up, and the parameters influencing the biochemical relapse (BR) were analysed. Out of 134 patients, 94 had clinically significant disease, specifically in 74.26% of the patients with PSA <10 ng/mL. Positive surgical margins and the extracapsular invasion were found in 29.1% and 51.4% patients, respectively. BR was observed in 29.6% of the patients. Cox regression evidenced a correlation between the BR and Gleason grade at the retropubic radical prostatectomy (RRP), capsular invasion, and the presence of positive surgical margins. Multivariate regression analysis showed a statistically significant correlation between the presence of surgical margins at the RRP and BR. Considering a single micro-focus of PC at the biopsy and PSA serum level <10 ng/mL, clinically significant disease was found in 74.26% patients and only positive surgical margins are useful for predicting the BR.</description><identifier>ISSN: 1687-8450</identifier><identifier>EISSN: 1687-8450</identifier><identifier>DOI: 10.1155/2012/645146</identifier><identifier>PMID: 22848218</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Limiteds</publisher><ispartof>Journal of Oncology, 2012-01, Vol.2012 (2012), p.486-491-051</ispartof><rights>Copyright © 2012 Gianluigi Taverna et al.</rights><rights>Copyright © 2012 Gianluigi Taverna et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a441t-6cda11f1a7303aff841819b86e49478b215bc6e9ef7358221a012501d201bc8f3</citedby><cites>FETCH-LOGICAL-a441t-6cda11f1a7303aff841819b86e49478b215bc6e9ef7358221a012501d201bc8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403479/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403479/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22848218$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Roach, M.</contributor><creatorcontrib>Taverna, Gianluigi</creatorcontrib><creatorcontrib>Benecchi, Luigi</creatorcontrib><creatorcontrib>Grizzi, Fabio</creatorcontrib><creatorcontrib>Seveso, Mauro</creatorcontrib><creatorcontrib>Giusti, Guido</creatorcontrib><creatorcontrib>Piccinelli, Alessandro</creatorcontrib><creatorcontrib>Benetti, Alessio</creatorcontrib><creatorcontrib>Colombo, Piergiuseppe</creatorcontrib><creatorcontrib>Minuti, Francesco</creatorcontrib><creatorcontrib>Graziotti, Pierpaolo</creatorcontrib><title>Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?</title><title>Journal of Oncology</title><addtitle>J Oncol</addtitle><description>Prostate cancer (PC) remains a cause of death worldwide. Here we investigate whether a single microfocus of PC at the biopsy (graded as Gleason 6 or less, ≤5% occupancy) and the PSA <10 ng/mL can define the archetype of low-risk prostate disease. 4500 consecutive patients were enrolled. Among them, 134 patients with a single micro-focus of PC were followed up, and the parameters influencing the biochemical relapse (BR) were analysed. Out of 134 patients, 94 had clinically significant disease, specifically in 74.26% of the patients with PSA <10 ng/mL. Positive surgical margins and the extracapsular invasion were found in 29.1% and 51.4% patients, respectively. BR was observed in 29.6% of the patients. Cox regression evidenced a correlation between the BR and Gleason grade at the retropubic radical prostatectomy (RRP), capsular invasion, and the presence of positive surgical margins. Multivariate regression analysis showed a statistically significant correlation between the presence of surgical margins at the RRP and BR. Considering a single micro-focus of PC at the biopsy and PSA serum level <10 ng/mL, clinically significant disease was found in 74.26% patients and only positive surgical margins are useful for predicting the BR.</description><issn>1687-8450</issn><issn>1687-8450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><recordid>eNqFks1u1DAUhSMEoqWwYg3yEoHC-CZO4myKplMoSIM64mdtOc71jEvGHuyk1bwLr8Ab8E68Ap6mDO2KhWVb99O51-c4SZ4CfQ1QFJOMQjYpWQGsvJccQsmrlLOC3r91PkgehXBBacloXT5MDrKMM54BP0x-zqQlkpx1KIOzpCTOkzmGQD4a5Z12agjEabLwLvSyRxJxhZ4YS84tkhPjNmFLpG33RPp5g8poo8jU9maJNspdYkd-__oBlNjlZD0nJ0hOURuLLZGB9CskU69W2G83uGs2d1fpJxO-_et6akKcD988Th5o2QV8crMfJV_fvf0ye5_Oz88-zKbzVDIGfVqqVgJokFVOc6k1Z8ChbniJrGYVbzIoGlVijbrKC55lIKOFBYU2WtkorvOj5HjU3QzNGluFtveyExtv1tJvhZNG3K1YsxJLdylyRnNW1VHgxY2Ad98HDL1Ym6Cw66RFNwQB1xivCojoqxGNfofgUe_bABW7gMUuYDEGHOnntyfbs38TjcDLEVgZ28or8x-1ZyOMEUEt9zDjVVXQWF-MdWm86Y24cIO30XixiCoFZDSntLpWjJpxq2g0k8Z_dvfCeFw1CBqf-wdiYs1n</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Taverna, Gianluigi</creator><creator>Benecchi, Luigi</creator><creator>Grizzi, Fabio</creator><creator>Seveso, Mauro</creator><creator>Giusti, Guido</creator><creator>Piccinelli, Alessandro</creator><creator>Benetti, Alessio</creator><creator>Colombo, Piergiuseppe</creator><creator>Minuti, Francesco</creator><creator>Graziotti, Pierpaolo</creator><general>Hindawi Limiteds</general><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><scope>188</scope><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120101</creationdate><title>Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?</title><author>Taverna, Gianluigi ; Benecchi, Luigi ; Grizzi, Fabio ; Seveso, Mauro ; Giusti, Guido ; Piccinelli, Alessandro ; Benetti, Alessio ; Colombo, Piergiuseppe ; Minuti, Francesco ; Graziotti, Pierpaolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a441t-6cda11f1a7303aff841819b86e49478b215bc6e9ef7358221a012501d201bc8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taverna, Gianluigi</creatorcontrib><creatorcontrib>Benecchi, Luigi</creatorcontrib><creatorcontrib>Grizzi, Fabio</creatorcontrib><creatorcontrib>Seveso, Mauro</creatorcontrib><creatorcontrib>Giusti, Guido</creatorcontrib><creatorcontrib>Piccinelli, Alessandro</creatorcontrib><creatorcontrib>Benetti, Alessio</creatorcontrib><creatorcontrib>Colombo, Piergiuseppe</creatorcontrib><creatorcontrib>Minuti, Francesco</creatorcontrib><creatorcontrib>Graziotti, Pierpaolo</creatorcontrib><collection>Airiti Library</collection><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taverna, Gianluigi</au><au>Benecchi, Luigi</au><au>Grizzi, Fabio</au><au>Seveso, Mauro</au><au>Giusti, Guido</au><au>Piccinelli, Alessandro</au><au>Benetti, Alessio</au><au>Colombo, Piergiuseppe</au><au>Minuti, Francesco</au><au>Graziotti, Pierpaolo</au><au>Roach, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?</atitle><jtitle>Journal of Oncology</jtitle><addtitle>J Oncol</addtitle><date>2012-01-01</date><risdate>2012</risdate><volume>2012</volume><issue>2012</issue><spage>486</spage><epage>491-051</epage><pages>486-491-051</pages><issn>1687-8450</issn><eissn>1687-8450</eissn><abstract>Prostate cancer (PC) remains a cause of death worldwide. Here we investigate whether a single microfocus of PC at the biopsy (graded as Gleason 6 or less, ≤5% occupancy) and the PSA <10 ng/mL can define the archetype of low-risk prostate disease. 4500 consecutive patients were enrolled. Among them, 134 patients with a single micro-focus of PC were followed up, and the parameters influencing the biochemical relapse (BR) were analysed. Out of 134 patients, 94 had clinically significant disease, specifically in 74.26% of the patients with PSA <10 ng/mL. Positive surgical margins and the extracapsular invasion were found in 29.1% and 51.4% patients, respectively. BR was observed in 29.6% of the patients. Cox regression evidenced a correlation between the BR and Gleason grade at the retropubic radical prostatectomy (RRP), capsular invasion, and the presence of positive surgical margins. Multivariate regression analysis showed a statistically significant correlation between the presence of surgical margins at the RRP and BR. Considering a single micro-focus of PC at the biopsy and PSA serum level <10 ng/mL, clinically significant disease was found in 74.26% patients and only positive surgical margins are useful for predicting the BR.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Limiteds</pub><pmid>22848218</pmid><doi>10.1155/2012/645146</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1687-8450 |
ispartof | Journal of Oncology, 2012-01, Vol.2012 (2012), p.486-491-051 |
issn | 1687-8450 1687-8450 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3403479 |
source | Wiley-Blackwell Open Access Titles; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
title | Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A20%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20a%20Gleason%206%20or%20Less%20Microfocus%20of%20Prostate%20Cancer%20in%20One%20Biopsy%20and%20Prostate-Specific%20Antigen%20Level%20%EF%BC%9C10%20ng/mL%20Be%20Defined%20as%20the%20Archetype%20of%20Low-Risk%20Prostate%20Disease?&rft.jtitle=Journal%20of%20Oncology&rft.au=Taverna,%20Gianluigi&rft.date=2012-01-01&rft.volume=2012&rft.issue=2012&rft.spage=486&rft.epage=491-051&rft.pages=486-491-051&rft.issn=1687-8450&rft.eissn=1687-8450&rft_id=info:doi/10.1155/2012/645146&rft_dat=%3Cproquest_pubme%3E1034798751%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1034798751&rft_id=info:pmid/22848218&rft_airiti_id=P20151203007_201212_201702210006_201702210006_486_491_051&rfr_iscdi=true |